Showing results (421-430 of 14,086) with videos related to

Sort By:
Pageof 1,409
Gynecologic Oncology|July 31, 2022
The association of endosalpingiosis with gynecologic malignancyGregory K Lewis, Summer Ghaith, Emily C Craver, et al.
Gynecologic Oncology|August 1, 2022
Real-world treatment drop-off among recurrent or metastatic cervical cancer patients: A US community oncology-based analysisZachary Alholm, Ding He, Jie Ting, et al.
Gynecologic Oncology|August 6, 2022
What happens after menopause? (WHAM): A prospective controlled study of symptom profiles up to 12 months after pre-menopausal risk-reducing salpingo-oophorectomyKatrina M Moss, Gita D Mishra, Efrosinia O Krejany, et al.
Gynecologic Oncology|September 11, 2021
Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019Jin Qin, Shahram Shahangian, Mona Saraiya, et al.
Gynecologic Oncology|September 11, 2021
Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancerZhenkun Wang, Ensong Guo, Bin Yang, et al.
Gynecologic Oncology|September 15, 2021
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL)Stephanie Gaillard, Ana Oaknin, Isabelle Ray-Coquard, et al.
Gynecologic Oncology|August 29, 2021
Perceived patient-centered communication, quality of life, and symptom burden in individuals with ovarian cancerRachel A Pozzar, Niya Xiong, Fangxin Hong, et al.
Gynecologic Oncology|August 29, 2021
Clinicopathological characteristics and prognostic factors of ovarian granulosa cell tumors: A JSGO-JSOG joint studyYasuhiko Ebina, Wataru Yamagami, Yoichi Kobayashi, et al.
Gynecologic Oncology|September 10, 2021
From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups?Sara Elisabeth Sponholtz, Ole Mogensen, Malene Grubbe Hildebrandt, et al.
Gynecologic Oncology|September 12, 2021
Adherence to PARP inhibitor therapy among women with ovarian cancerHaley A Moss, Ling Chen, Dawn L Hershman, et al.
Pageof 1,409